International Patent: CANCER RISK ASSESSMENT MODEL BASED ON LOW-PASS CFDNA SEQUENCING DATA AND USE THEREOF

GENEVA, July 27 -- OMIXSCIENCE (SHENZHEN) CO., LTD. filed a patent application (CN2026/072242) for “CANCER RISK ASSESSMENT MODEL BASED ON LOW-PASS CFDNA SEQUENCING DATA AND USE THEREOF”. With publication no. WO/2026/153310, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 30/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....